James Hassard - Chief Commercial Officer at Crinetics Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Commercial Officer
Stock Symbol
CRNX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by James Hassard since 11/21/2024

Holdings reported by James Hassard for Crinetics Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 29.3K $1.29M $44.08 Jul 5, 2024 Direct
Stock option (Right to Buy) 130K Jul 5, 2024 Direct Common Stock

Transactions reported by James Hassard for Crinetics Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.